6-K - Alterity Therapeutics Limited | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Alterity Therapeutics Limited filed a Form 6-K on March 26, 2026, submitting Exhibit 99.1, a notification regarding unquoted securities under the identifier ATH 1. This disclosure is incorporated by reference into multiple registration statements and signed by Chairman Julian Babarczy.

Key Takeaways

1Exhibit 99.1: Notification regarding unquoted securities - ATH 1

2Filing date: March 26, 2026

3Signed by Julian Babarczy, Chairman

4Incorporated into Form S-8 (Files No. 333-251073, 333-248980, 333-228671)

5Incorporated into Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076)

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (2)

6-K

FORM 6-K

99.1

EXHIBIT 99.1